BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34656041)

  • 21. Synthesis and in vitro evaluation of novel spiroketopyrazoles as acetyl-CoA carboxylase inhibitors and potential antitumor agents.
    Huang T; Wu X; Yan S; Liu T; Yin X
    Eur J Med Chem; 2021 Feb; 212():113036. PubMed ID: 33276990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells.
    Meng C; Qian J; Xu Z; Liu J; Shan W; Zhu P; Zhu W; Miao J; Ling CC; Ling Y
    Bioorg Chem; 2020 Dec; 105():104360. PubMed ID: 33074118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of
    Chen W; Chen X; Li D; Zhou J; Jiang Z; You Q; Guo X
    J Med Chem; 2021 Jun; 64(12):8221-8245. PubMed ID: 34105966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel potent migrastatic Thiazolo[5,4-b]pyridines targeting Lysyl-tRNA synthetase (KRS) for treatment of Cancer metastasis.
    Lee S; Kwon NH; Seo B; Lee JY; Cho HY; Kim K; Kim HS; Jung K; Jeon YH; Kim S; Suh YG
    Eur J Med Chem; 2021 Jun; 218():113405. PubMed ID: 33831781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of selenopsammaplin A and its analogues as antitumor agents with DOT1L inhibitory activity.
    Ju Han H; Sub Byun W; Ho Lee G; Kyung Kim W; Jang K; Yang S; Yang J; Woo Ha M; Hong S; Lee J; Shin J; Bong Oh K; Kook Lee S; Park HG
    Bioorg Med Chem; 2021 Apr; 35():116072. PubMed ID: 33636429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of sulfonamides and 9-oxo-2,8-diazaspiro[5,5]undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors.
    Kalliokoski T; Rummakko P; Rantanen M; Blaesse M; Augustin M; Ummenthala GR; Choudhary S; Venäläinen J
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127060. PubMed ID: 32113843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
    Cowen SD; Russell D; Dakin LA; Chen H; Larsen NA; Godin R; Throner S; Zheng X; Molina A; Wu J; Cheung T; Howard T; Garcia-Arenas R; Keen N; Pendleton CS; Pietenpol JA; Ferguson AD
    J Med Chem; 2016 Dec; 59(24):11079-11097. PubMed ID: 28002961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
    Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
    J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.
    Yang X; Wedajo W; Yamada Y; Dahlroth SL; Neo JJ; Dick T; Chui WK
    Eur J Med Chem; 2018 Jan; 144():262-276. PubMed ID: 29274493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2).
    Methot JL; Hamblett CL; Mampreian DM; Jung J; Harsch A; Szewczak AA; Dahlberg WK; Middleton RE; Hughes B; Fleming JC; Wang H; Kral AM; Ozerova N; Cruz JC; Haines B; Chenard M; Kenific CM; Secrist JP; Miller TA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6104-9. PubMed ID: 18951790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design and discovery of potent and selective KDM5 inhibitors.
    Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
    Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael-aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity.
    Wang S; Chen S; Guo Z; He S; Zhang F; Liu X; Chen W; Zhang S; Sheng C
    Org Biomol Chem; 2018 Jan; 16(4):625-634. PubMed ID: 29302672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J
    Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
    Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
    Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
    Rabal O; San José-Enériz E; Agirre X; Sánchez-Arias JA; Vilas-Zornoza A; Ugarte A; de Miguel I; Miranda E; Garate L; Fraga M; Santamarina P; Fernandez Perez R; Ordoñez R; Sáez E; Roa S; García-Barchino MJ; Martínez-Climent JA; Liu Y; Wu W; Xu M; Prosper F; Oyarzabal J
    J Med Chem; 2018 Aug; 61(15):6518-6545. PubMed ID: 29953809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
    Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
    Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship.
    Wu S; Li Y; Xu G; Chen S; Zhang Y; Liu N; Dong G; Miao C; Su H; Zhang W; Sheng C
    Eur J Med Chem; 2016 Jun; 115():141-7. PubMed ID: 27016707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
    Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
    Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors.
    Nepali K; Chang TY; Lai MJ; Hsu KC; Yen Y; Lin TE; Lee SB; Liou JP
    Eur J Med Chem; 2020 Jun; 196():112291. PubMed ID: 32325365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.